Feedback / Questions
BEL512 - Belenos Biosciences
https://www.businesswire.com/news/home/20260811141838/en/Belenos-Biosciences-Announces-Positive-Topline-Results-from-a-Phase-2-Clinical-Trial-of-BEL512-in-Chronic-Rhinosinusitis-with-Nasal-Polyps-CRSwNP
Aug 11, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next